Rare diseases
Investigational molecules
Locations
Comparing the efficacy and safety of KAI-9531 and semaglutide in people living with obesity who do not have diabetes
BulgariaStudy of linaprazan glurate and lansoprazole to maintain healing in patients with erosive esophagitis caused by acid reflux disease
BulgariaEfficacy and Safety of MET097 Once Weekly in People with Overweight or Obesity and Type 2 Diabetes
BulgariaA study to evaluate the efficacy and safety of MET097 in people with obesity or overweight.
BulgariaA study to evaluate the safety and effectiveness of galvokimig in adults with moderate to severe atopic dermatitis
BulgariaA study to evaluate the effect of olpasiran on major cardiovascular events in patients with atherosclerotic cardiovascular disease and high levels of lipoprotein(a)
BulgariaA study testing cagrilintide and semaglutide for heart safety in people with cardiovascular disease
BulgariaA study comparing ziltivekimab to placebo in patients with heart failure with mildly reduced or preserved ejection fraction and inflammation
BulgariaStudy of Navenibart to prevent attacks in adults and adolescents with Hereditary Angioedema
BulgariaComparison of zasocitinib and deucravacitinib in adults with moderate to severe plaque psoriasis
BulgariaStudy of zasocitinib (TAK-279) and apremilast compared to placebo in adults with moderate to severe plaque psoriasis
BulgariaStudy of Rocatinlimab Treatment for Adults and Adolescents with Moderate to Severe Atopic Dermatitis
BulgariaTell us about your condition – we search every trial in Europe and connect you with the right site.
